Argonne National Laboratory Biosciences Division
> Publications
Argonne Home > BIO home > Fred J. Stevens

Fred J. Stevens

Publications by Author,
Select Publication Author
 
   
     

ABSTRACTS/PRESENTATIONS:

  1. Stevens, F.J. and T.T. Wu. 1974. A third stage mutant of E. coli capable of utilizing
    he polyhydric pentitols as sole source of carbon and energy. Abstr. Ann. Mtg. Am.
    Soc. Microbiol., p 156.

  2. Stevens, F.J. and T.T. Wu. 1976. Acquisition by E. coli K 12 of the ability to utilize
    an unnatural pentose, D lyxose. Federation Proc. 35: 1660.

  3. Stevens, F.J. and R.L. Uffen. 1977. Acquisition of photosynthetic competence by
    anaerobic dark grown cells of R. rubrum exposed to light. Presented at 4th Ann. Mtg. on the
    Molec. Biol. of Photosyn. Microorganisms; May 7.

  4. Stevens, F.J., H.S. Pankratz, and R.L. Uffen. 1977. Cytochemical and spectrophotometric
    examination of the effect of glutaraldehyde on the oxidation of 3,3' diaminobenzidine in
    phototropic bacteria. Cell Biology 75: 244a.

  5. Stevens, F.J., F. Westholm, A. Solomon, and M. Schiffer. 1979. Heterogeneity of
    κI light chains. Federation Proc. 38: 940.

  6. Stevens, F.J., F.A. Westholm, A. Solomon, and M. Schiffer. 1979. Role of the third
    hypervariable region in the self association of κI immunoglobulin light chains.
    Presented at Midwest Autumn Immunology Conference; November 5.

  7. Stevens, F.J., F.A. Westholm, A. Solomon, and M. Schiffer. 1980. Computer simulation
    of small zone gel filtration: heterologous association of immunoglobulin light chains.
    Federation Proc. 39: 2210.

  8. Schiffer, M., F.J. Stevens, F. Westholm, D. Carlson, and B. Schoenborn. 1980. Small angle
    neutron scattering study of Bence Jones protein Mcg: comparison of structures in solution
    and in crystal. Presented at Gordon Conference on Diffraction Methods in Molecular Biology;
    June 21.

  9. Peraino, C., and F.J. Stevens. 1980. Characteristics of liver tumor promotion by
    phenobarbital. Presented at Symposium on Cocarcinogenesis and Biological Effects of
    Tumor Promoters; Oct. 13 (Klais, West Germany).
  10. Schiffer, M., F.J. Stevens, and F.A. Westholm. 1980. Structural properties of Bence Jones
    proteins in the crystal and in solution. 38th Annual Pittsburgh Diffraction Conference; Oct. 30.

  11. Wu, T.T., P.W. Stevens, J.G. Hovis, and F.J. Stevens. 1981. Production of an evolutionary
    remnant enzyme in Escherichia coli K 12. FEMS Symposium on Overproduction of Microbiol
    Products. Abstracts, p. 43.

  12. Short, M., F.J. Stevens, F. Westholm, A. Solomon, and M. Schiffer. 1980. Preliminary X ray
    crystallographic studies of Bence Jones protein Loc. Presented at Midwest Autumn Immunology
    Conference; Oct. 18.
  13. Short, M., F.J. Stevens, F. Westholm, A. Solomon, and M. Schiffer. 1982. Crystallographic
    investigation of lambda Bence Jones protein Loc. Federation Proc. 41: 287.

  14. Short, M.T., F.J. Stevens, and M. Schiffer. 1983. High pressure gel permeation chromatography
    in the study of self associating immunoglobulin I light chains and an idiotype anti idiotype
    complex. Federation Proc. 42: 931.

  15. Stevens, F.J., S. Anaokar, G. Korom, J. Tice, and P. Spillar. 1983. Solid phase enzyme
    immunoassay for serum leutenizing hormone. Clin. Chem. 29: 1241.

  16. Schiffer, M., R.L. McMasters, C. H. Chang, and F.J. Stevens. 1984. Interactions of
    immunoglobulin constant domains. Gordon Research Conference on Physics and Physical
    Chemistry of Biopolymers; June 27.

  17. Stevens, F.J. and C.F. Ainsworth. 1985. Antibody antigen interactions: application of
    chromatography simulation and laboratory microcomputer. Federation Proc. 44: 1077.

  18. Stevens, F.J. 1985. Application of microcomputer controlled size exclusion chroatography and
    computer simulation to analysis of macromolecular interactions. Presented at Amoco sponsored
    University/Industry Poster Session; Oct. 23 (Naperville, IL).

  19. Schiffer, M., C. H. Chang, F.J. Stevens, and A. Solomon. 1985. Implications of the protruding
    binding site of light chain dimer Loc for the structure of the anti idiotypic antibody. Presented at
    Symposium Idiotype Networks and Immune Regulation: Potential Uses in Vaccines and In
    Understanding Human Diseases; December 4 (San Antonio).

  20. Stevens, F.J. and M. Schiffer. 1985. Analysis of idiotype:anti idiotype interactions by small zone
    size exclusion chromatography: consideration of equilibrium constant and rate constants.
    Presented at Symposium Idiotype Networks and Immune Regulation: Potential Uses in Vaccines
    and In Understanding Human Diseases; December 4 (San Antonio).

  21. Stevens, F.J. and C.F. Ainsworth. 1986. Microcomputer controlled size exclusion
    chromatography. Biophys. J. 49: 88a.

  22. Carperos, W., J. Jwo, and F.J. Stevens. 1986. Analysis of monoclonal antibodies by liquid
    chromatography. Presented at Abbott Laboratories, State of Illinois Sponsored Poster Session;
    November 26 (North Chicago, IL).

  23. Boernke, W.E. and F.J. Stevens. 1987. HPLC based size exclusion chromatography for the
    detection of interactions between nucleic acids and proteins. Biophys. J. 51: 442a.

  24. Stevens, F.J. and M. Schiffer. 1987. Modification of an ELISA based method to determine
    affinity: correction for nonlinear relationship between occupancy of antibody binding sites and
    attachment of IgG to immobilized antigen. Federation Proc. 46: 491.

  25. Stevens, F.J. 1987. Simulation of macromolecular interactions: kinetically controlled
    elution characteristics during size exclusion high performance liquid chromatography. Presented at Amoco sponsored University Industry Poster Session; Oct 8 (Naperville, IL).

  26. Carperos, W.E. and F.J. Stevens. 1987. Application of size exclusion high performance liquid
    chromatography for the measurement of antibody antigen dissociation rate constants. Presented
    at Amoco sponsored University Industry Poster Session; Oct 8 (Naperville, IL).

  27. Stevens, F.J. 1987. Macromolecular interactions: kinetically controlled elution characteristics
    during size exclusion HPLC. Presented at Conference on Biotechnology Research Directions:
    Biomolecules; Nov 6 (Argonne, IL)

  28. Carperos, W.E. and F.J. Stevens. 1987. Application of size exclusion high performance liquid
    chromatography for the measurement of antibody antigen dissociation rate constants. Presented
    at Conference on Biotechnology Research Directions: Biomolecules; Nov 6 (Argonne, IL)

  29. Schiffer, M., C. H. Chang and F.J. Stevens. 1987. Domain domain interactions affect the
    expression of idiotope. Presented at Symposium on Idiotype Networks and Immune Regulation:
    II Autoimmunity, Cancer, Receptors and Vaccines; Nov 18 (San Antonio).

  30. Stevens, F.J. 1988. Simulation of kinetically controlled elution characteristics exhibited
    by macromolecular interactions during size exclusion HPLC. Biophys. J. 53: 400a.

  31. Stevens, F.J., and P. Kaumaya. 1988. Size exclusion HPLC analyses of protein and peptide
    epitopes. Presented at Second Conference on Biotechnology Research Directions: Biomolecules;
    Nov 4 (Argonne, IL)

  32. Schiffer, M., C. H. Chang, Z.B. Xu and F.J. Stevens. 1989. Modification of antibody binding
    site through altered V V domain interactions. J. Cell. Biol. 13A:94.

  33. Boernke, W.E. and F.J. Stevens. 1989. Study of interactions between myeloperoxidase and
    nucleic acids by size exclusion HPLC. Biophys. J. 55: 525a.

  34. Stevens, F.J., and P. Kaumaya. 1989. Size exclusion HPLC analyses of peptide epitopes.
    FASEB J. 3: A1135.

  35. Schiffer, M., C. H. Chang, Z B. Xu and F.J. Stevens. 1989. Conformational effects and diversity
    of antibodies. Presented at 7th International Congress of Immunology, (Berlin).

  36. Spangler, B.D., F.J. Stevens, and E.M. Westbrook. 1989. Binding of monoclonal antibodies to
    cholera toxin: comparison of solid phase and solution phase techniques. Presented at
    Amoco sponsored University Industry Poster Session; Oct 12 (Naperville, IL).

  37. Stevens, F.J. 1990. Simulation of macromolecular interactions during size exclusion
    chromatography: positive cooperativity contribution by gel matrix. Biophys. J. 57: 82a.

  38. Stevens, F.J. 1990. Chromatographic analyses of protein:protein interactions: from the
    supercomputer to the kidney. Presented at the University of Illinois at Chicago, Dept. of
    Biochemistry; April 19.

  39. Stevens, F.J. 1990. Chromatographic analyses of macromolecular interactions: from the
    supercomputer to the kidney. Presented at the Wayne State University, Dept. of Biochemistry;
    Sept 4.

  40. Stevens, F.J. 1990. Biophysical aspects of myeloma pathology. University of Tennessee Knoxville,
    School of Medicine; Sept 7.

  41. Myatt, E.A. and F.J. Stevens. 1991. Induction of protein aggregation in nephromimitic solutions.
    Biophys. J. 59: 119a.

  42. Shen, B., F.J. Stevens, and U. Luthi. 1991. Elasticity of human erythrocyte spectrin inferred from
    conformational analysis. FASEB J. 5: A685.

  43. Myatt, E.A. and F.J. Stevens. 1991. Induction of protein aggregation in nephromimitic solutions. Presented at Gordon Research Conference; June 17 21.

  44. Spangler, B.D., G.D. Armstrong, and F.J. Stevens. 1991. HPLC analysis of pertussis binding to
    glycoproteins. Presented at fifteh European Workshop on Bacterial Protein Toxins, Veldhoven, July.

  45. Chen, S., S. Goldin, F.J. Stevens, and B.W. Shen. 1991. Elasticity of human erythrocyte spectrin
    inferred from electron microscopic and conformational analysis. Presented at Gordon Research
    Conference, Plymouth State College, New London, N.H.; August 5 9.

  46. Stevens, F.J. 1991. Polymerization of immunoglobulin domains: a model system for the development of facilitated macromolecular assembly. (Presented at the Second Foresight Conference on Molecular Nanotechnology, Palo Alto, CA; (November 7 9)).

  47. Stevens, F.J. 1991. Biophysical and computational aspects of immunoglobulin light chain
    pathology. Chicago Medical School, North Chicago, IL. Dept of Biochemistry; November 21.

  48. Stevens, F.J., E.A. Myatt, A. Solomon, and M. Schiffer. 1992. Amyloidosis AL: Molecular
    model for a biophysical disease. Biophys. J. 61: A211

  49. Stevens, F.J. and R.L. Stevens. 1992. Protein protein interaction kinetics. Presented at
    Concurrent Supercomputing Consortium Workshop, CalTech, February 11.

  50. Harrison, H.H., T. Godsey, K. Bedford, A. Katta, K. Miller, E. Weisenberg, J.E. Bowman, E.Myatt, C.S. Giometti, and F.J. Stevens. 1992. Comparison of microheterogeneity patterns of purified monoclonal light chains (Bence Jones proteins) and polyclonal free light chains that produce the pseudo oligoclonal (“ladder light chain”') pattern in immunofixation studies of urine. Clin. Chem.

  51. Stevens, F.J. 1992. Analysis of antibody light chain interactions: modeling of amyloid fibril
    formation. Presented at Northern Illinois University, De Kalb, IL, Oct. 2.

  52. Gaasterland, T., R.L. Stevens, F.J. Stevens, and M. Schiffer. Critiquing protein molecule
    structures. Presented at The Third Keck Symposium on Computational Biology, Houston, TX,
    Nov. 1 3, 1992.
  53. Myatt, E.A., A. Solomon, and F.J. Stevens. Aggregation of immunoglobulin light chains.
    J. Immunol. 150: 861, 1993.

  54. Li, D., F.J. Stevens, M. Schiffer, and L.E. Anderson. Cysteine clusters in the light activated
    chloroplast enzymes. Plant Physiol. 102: 37, 1993.

  55. Li, D., F.J. Stevens, M. Schiffer, and L.E. Anderson. Identification of redox sensitive cysteines
    distal to catalytic site in light activated chloroplastic glyceraldehyde 3 phosphate dehydrogenase
    by modeling. Presented at The XIII Midwest Enzyme Conference, Loyola University, Oct 9, 1993.

  56. Huang, D. B., C. H. Chang, C. Ainsworth, M. Schiffer, F.J. Stevens, A. Brunger, M. Eulitz, and
    A. Solomon. Novel immunoglobulin variable domain interaction is observed. ACA Meeting,
    Albuquerque, PK14, 1993.

  57. Jiang, X., P. Lykos, M. Schiffer, and F.J. Stevens. The design and evaluation of the peptide
    inhibition of antibody light chain dimer formation by molecular modeling. Presented at The
    Second Annual Development of Small Molecule Mimetic Drugs, Philadelphia, April 11 12, 1994.

  58. Stevens, F.J. A molecular model for amyloid fibril formation by antibody light chains.
    Presented at Loyola University, Chicago, April 21, 1994.

  59. Li, D., F.J. Stevens, M. Schiffer, and L.E. Anderson. Mechansims of light modulation:
    identification of potential redox sensitive cysteines in chloroplast fructose 1,6 bisphosphatase
    and sedoheptulose 1,7 bisphosphatase. FASEB J. 8: A1290, 1994.

  60. Muslin, E.H., D. Li, M. Schiffer, F.J. Stevens, M.I. Donnelly, and L. Anderson. Construction of a
    redox sensitive malate dehydrogease. Presented at XIV Annual Midwest Autumn Enzymology
    Conference. 1994

  61. Stevens, F.J. Physcial chemical aspects of antibody interactions with itself, antigen, and solid
    surfaces. Presented at Surfaces in Biomaterials '94, Scottsdale, AZ., Sept 8 10, 1994.

  62. Li, D., E. H. Muslin, L.E. Anderson, M.M. Pacold, M. Donnelly, M. Schiffer, and F.J. Stevens.
    Engineering a domain-locking disulfide into a bacterial malate dehydrogenase produces a redox-
    sensitive enzyme. FASEB J. 9:A1284, 1995.

  63. Paul, S., L. Li, P. Wilkins-Stevens, F.J. Stevens, and A.Solomon. Natural catalytic antibodies:
    peptide hydrolyzing activities of monoclonal human light chains and VL fragment. FASEB J 9:
    1265, 1995.

  64. Kalaga, R., H. Huang, F.J. Stevens, A. Solomon, and S. Paul. gp120 hydrolysis by catalytic
    antibody light chain. Presented at The 9th International Congress of Immunology, San Fransisco,
    CA, July 23-29, 1995.

  65. 65. Jiang, X.-L., E.A. Myatt, R. Raffen, and F.J. Stevens. Study of interactions between amyloid
    forming protein and glycosaminoglycans. Presented at Protein Interactions. Pfizer/Beckman
    Institute Protein Symposium. Urbana, IL, June 1-4, 1995.

  66. 66. Anderson, L.E., H.C. Huppe, D. Li, and F.J. Stevens. Identification of a potential recdox
    -sensitive inter-domain disulfide in the sedoheptulose bisphosphatase of Chlamydomonas
    reinhardtii. Presented at Xth International Photosynthesis Congress, Montpellier, France,
    August 20-25, 1995.

  67. Stevens, F.J. Molecular studies of light chain amyloidosis. Presented at FASEB Conference:
    Amyloid and other Abnormal Protein Assembly Processes, Copper Mountain, CO, August 20-
    25, 1995.

  68. Mulsin, E.H., F.J. Stevens, and L.E. Anderson. A disulfide bridge stabilizes anaerobically
    induced lactate dehydrogenase in barley. Presented at Thoiredoxins and Related Proteins,
    Witzenhausen, University of Kassel, August 27-31, 1995.

  69. Anderson, L.E., D. Li, E.H. Muslin, M.E. Pacold, M.I. Donnelly, M. Schiffer, and F.J. Stevens.
    Mechanism of light modulation: Identification of redox-sensitive cysteines in malate
    dehydrogenase by modeling and by site-directed mutagenesis. Presented at Thioredoxins and
    Related Proteins, Witzenhausen, University of Kassel, August 27-31, 1995.

  70. Muslin, E.H., F.J. Stevens, and L.E. Anderson. Anaerobically induced lactate dehydrogenase:
    The role ofa disulfide bridge in enzyme stability. Presented at XV Annual Midwest Autumn
    Enzymology Conference. Chicago, IL. Oct 15, 1995

  71. Li, A.D., H.C. Huppe, F.J. Stevens, and L.E. Anderson. Chlamydomonas reinhardtii NADP-
    linked glyceraldehyde-3-phosphate dehydrogenase is DTT-activatable. Presented at XV Annual
    Midwest Autumn Enzymology Conference. Chicago, IL. Oct 15, 1995

  72. Anderson L.E., A. D. Li, E.H. Muslin, M.E. Pacold, M.I.Donnelly, M. Schiffer, and F.J. Stevens
    1995. Mechansim of light modulation: identification of redox-sensitive cysteines in target
    enzymes by modeling and by site-directed mutagenesis. Presented at XV Annual Midwest
    Autumn Enzymology Conference. Chicago, IL. Oct 15.

  73. Muslin E.H., A. D. Li, F.J. Stevens, M. Schiffer, M. Donnelly, and L.E. Anderson. 1995. The
    engineering of new domain-locking disulfides into a bacterial malate dehydrogenase strengthens
    evidence for original model of reductive activation of the chloroplast enzyme. Presented at
    Photosynthesis Symposium, Turkey Run, IN, Oct.

  74. Raffen, R., P. Wilkins Stevens, D.K. Hanson, Y. Deng, M. Berrios-Hammond, F.A. Westholm,
    M. Schiffer, and F.J. Stevens. 1996. In vitro characterization of light chain amyloidosis using
    recombinant light chain variable domains. Biophysical J.

  75. Levine, D. and F.J. Stevens. 1996. STALK: A Molecular Docking System. Presented at
    The Second Sandia National Laboratories Workshop on Computational Molecular Biology,
    March 4 6, 1996, Albuquerque, New Mexico

  76. Huang, D.-B., C. Ainsworth, C.-H. Chang, F.J. Stevens, and M. Schiffer. 1996. Structure of the
    variable domain of human immunoglobulin IV light chain Len Presented at the International
    Union of Crystallography XVII Congress and General Assembly, Seattle, WA., Aug 8-17.

  77. Stevens, F.J. 1996. Biophysical pathology of human antibody light chains. Presented at NYU
    Medical School, New York, Nov 26.

  78. Khurana, R., F.J. Stevens, S. Meredith, and Y. Argon. 1997. Interaction of BiP with partially
    unfolded variable domain of immunoglobulin light chain. Presented at Keystone Conference,
    March.

  79. Schiffer, M., D.-B. Huang, R. Raffen, R. Pokkuluri, P. Wilkins-Stevens, and F.J. Stevens. 1997.
    Major unexpected effect of a Gln to Glu substitution on a dimer interface. 1997 Proteins Gordon
    Conference.

  80. Raffen, R., L.J. Dieckman, P. Wilkins Stevens, P.R. Pokkuluri, M. Schiffer, and F.J. Stevens.
    1997. Characterizing primary structural determinants of immunoglobulin light chain amyloidosis
    with recombinant light chain variable domains. FASEB Summer Research Conference on
    "Amyloid and other Abnormal Protein Assembly, July 13-18, Copper Mt. CO.

  81. Pokkuluri, P.R., D.-B. Huang, R. Raffen, P. Wilkins-Stevens, F.J. Stevens, and M. Schiffer.
    1997. How do metal ions help (promote) the formation of protein crystals? The Annual
    American Crystallographic Association Meeting, July 19-25, St. Louis, MO.

  82. Stevens, F.J. 1997. Conformational diseases of immunoglobulins. Presented at University
    of Chicago, Dept of Pathology, Oct 13.

  83. Stevens, F.J. 1997. Amino acid sequences, protein bioophysics and the pathological expression
    of light chains. Presented at the 30th Annual Meeting of the American Society of Nephrology,
    San Antonio, Nov 2-5.

  84. Deret, S., J. Chomilier, F. Stevens, and P Aucouturier. 1997. Particularites structurales des chaines
    legeres d’immunoglobulines responables de la maladie des depots de chaines legeres (LCDD).
    Presented at the 10 Annual Meeting of the GGMM (Groupe du Graphisme et Modelisation
    Moleculaire), Dourdan, France.

  85. Stevens, F.J. 1998. Conformational diseases of antibody light chains. Presented at University of
    Illinois, Chicago, Feb 12.
  86. Pokkuluri, P.R., G. Johnson, X. Cai, L. Dieckman, F.J. Stevens, and M. Schiffer. 1998.
    Domain flips resulting from single amino acid substitutions. American Crystallographic
    Association Meeting.

  87. Schiffer, M., P.R. Pokkuluri, X. Cai, G. Johnson, R. Raffen, and F.J. Stevens. 1998. A single
    amino acid substitutions changes the mode of dimerization. Presented at The Thrid Annual
    Structural Biology Symposium, University of Texas Medical Branch at Galveston, April 3-5.

  88. Dogar, J. and F.J. Stevens. 1998. Use of computerized homology modeling and threading
    techniques to predict immunodominant epitopes of Fel d 1 on MHC Class-II molecules.
    Presented at Aspen Allergy Conference, July 29 - Aug1.

  89. Raffen, R., P.R. Pokkuluri, P. Wilkins Stevens, M. Schiffer, and F.J. Stevens. 1998.
    Characterization of immunoglobulin light chain amyloidosis by site-directed mutagenses.
    Presented at Protein Society Symposium, San Diego, CA., July 25-29.

  90. Stevens, F.J. 1998. Applications of protein engineering: From a killer protein to detection of
    actinides. Presented at Northwestern University, Dept. of Biomedical Engineering, Dec 3.

  91. Stevens, F.J., R. Raffen, L. J. Dieckman, M. Szpunar, P.R. Pokkuluri, P.W. Stevens, and M. Schiffer. 1999. Characterization of immunoglobulin light chain pathoenic aggregation and amyloidosis by site-directed mutagenesis. Presented at 4th Annual Midwest Stress Response and Chaperone Meeting., Jan 16.

  92. Davis, D.P., S. Vogen, C. Case, R. Raffen, F. Stevens, and Y. Argon. 1999. Unlocking the
    mechanisms of immunoglobulin aggregation disorders. Presented at 4th Annual Midwest Stress
    Response and Chaperone Meeting, Jan 16.

  93. Schiffer, M., P.R. Pokkulur, R. Raffen, X. Cai, G. Johnson, and F.J. Stevens. 1999. Alteration of
    dimerization mode by single amino substitutions. Presented at 13th Symposium of the Protein
    Society, Boston, MA, July 24-28.

  94. Li, A.D., L.E. Anderson, M. Schiffer, and F.J. Stevens. 1999. Identifying potential disulfides by
    homology modeling. Presented at XVIth International Botanical Congress, St. Louis, Aug 1-7.

  95. Anderson, L.E., A.D. Li, and F.J. Stevens. 1999. Identification of potential redox-sensitive
    cysteine residues in the reductase domains of two plant dihydrofolate reductase-thymidylate
    synthases. Presented at XVIth International Botanical Congress, St. Louis, Aug 1-7.

  96. Anderson, L.E., A.D. Li, and F.J. Stevens. 1999. Finding redox-regulated enzymes by homology
    modeling. Presented at Russian Society for Plant Physiology meeting, Moscow, Oct.

  97. Dong, A., Y.-S. Kim, R. Raffen, T.W. Randolph, A. Solomon, P. Wilkins Stevens, F.J. Stevens,
    and J.F. Carpenter. 2000. Entrapping aggregation intermediates of α-helix and β-domain proteins
    by thermochemical denaturation: an infrared spectroscopic study. Presented at FASEB
    Conference: Amyloid and other Abnormal Protein Assembly Processes, Copper Mountain, CO,
    June 11-16.

  98. Kim, Y.-S., S.P., E. Chi, R. Raffen, P.Wilkins Stevens, F.J. Stevens, A. Solomon, M.C.
    Manning, T.W. and J.F. Carpenter. 2000. Counteracting effects of renal solutes on amyloid fibril
    formation by immunoglobulin light chains. Presented at FASEB Conference: Amyloid and other
    Abnormal Protein Assembly Processes, Copper Mountain, CO, June 11-16.

  99. Stevens, F.J. and S. Filer. 2000. Novel strategy using synthetic nucleic acids and conventional
    immunoassays for biological agent detection. Third International Symposium; Chemical and
    Biological Medical Treatment Symposia (CBMTS). AC-Laboratorium, Spiez, Switzerland,
    May 7-12.

  100. Manning, M.C., R. Meglan, and F.J. Stevens. 2000. Decoding the sequences of antibody light
    chains: the power of multivariate statistical analysis. Presented at the 2000 Colorado Protein
    Stability Conference, Breckenridge, Colorado, July 13-15.

  101. Davis, D.P., K. Sciarretta, S.M. Vogen, J. L. Dul, F.J. Stevens, and Y. Argon. 2001. Both somatic
    mutation and environmental factors govern the aggregation pathway. Canadian Society of
    Biochemistry and Molecular & Cellular Biology. 11th Winternational Conference: “Dynamics of
    Intracellular Organelles and Molecular Machines.” Mont Ste. Anne, Feb 8-11.

  102. Dul, J.L., D.P. Davis, E.K. Williamson, F.J. Stevens, and Y. Argon. 2001. Hsp70 and anti-
    fibrillogenic peptides promote degradation and inhibit intracellular aggregation of amyloidogenic
    light chains. Canadian Society of Biochemistry and Molecular & Cellular Biology.
    11th International Conference: “Dynamics of Intracellular Organelles and Molecular
    Machines.” Mont Ste. Anne, Feb 8-11.

  103. Stevens, F.J. 2001. Protein structure, biophysics, and disease. Presented at Northern Illinois
    University, April 20.

  104. Wan, K., M. Duan, Y.-M. Lin, Y.-M., J. Lin, R. Raffen, and F.J. Stevens. 2001. The study of
    protein-protein interactions by H/D exchange and ESI MS. Presented at 49th Annual Conference
    on Mass Spectrometry and Allied Topics, Chicago, IL, May 27-May31.

  105. Stevens, F.J. 2001. Protein structure, biophysics, and disease. Presented at MediChem Research,
    Inc. Woodridge, IL, June 5.

  106. Silver, R.B., J.R. Hummel, J.H. Christiansen, S.R. Filer, and F.J. Stevens. 2001. A multi-modal biosensor and decision system. Presented at 5th Joint Conference on Standoff and Detection, Williamsburg, VA, Sept 24-27, 2001.

  107. Stevens, F.J. 2002. The challenge of the megaproteins: Speculations on the structures of BRCA1 and BRCA2. Presented at the University of Illinois at Chicago, Bioengineering Dept, Sept 20.

  108. Stevens, F.J. 2003. BRCA1 and BRCA2: Structure predictions without significant homology: soluble domains, functional validation. Presented at the University of Chicago, Feb 14.

  109. Stevens, F.J. 2003. New directions for analysis of megaproteins and other inhabitants of the twilight and midnight zones. Presented at Advanced Life Sciences, Woodridge, Il, June 13.

  110. Stevens, F.J. 2003. Structural relevance of germline gene to light chain amyloidosis. Presented at Mayo Clinic, Rochester, MN, Sept 24.

  111. Stevens, F.J. 2003. Structural insights from sequence analysis. Presented at Children’s Hospital of Philadelphia, Oct 1.

  112. Stevens, F.J. 2003. Protein self-assembly: a normal process, a pathological process, a nanotechnical process. Presented at Argonne National Laboratory, Nanolunch seminar series, Oct 15.

  113. Stevens, F.J. 2003. Recognition of protein fold (and sometimes function) from sequence at very low levels of identity. Presented at Bioinformatics Workshop, Ft. Detrick, Md. Nov 5.

  114. Wilton, R, P. Saxena, and F.J. Stevens. Expression, purification, and biochemical characterization of the human receptor for advanced glycation endproducts (RAGE). Presented 18th Symposium of the Protein Society, San Diego, Aug 14-18, 2004.

PUBLICATIONS (book chapters):

  1. Stevens, F.J. and C. Peraino. 1982. Development of a model to simulate the characteristics of
    rat liver tumor promotion by phenobarbital. In Proceedings of the Symposium on
    Cocarcinogenesis and Biological Effects of Tumor Promoters, eds. E. Hecker, N.E. Fusenig, W.
    Kunz, F. Marks, and H.W. Thielmann, pp. 105 109, Raven Press, New York.

  2. Wu, T.T., P.W. Stevens, J.G. Hovis, and F.J. Stevens. 1982. Production of an evolutionary
    remnant enzyme in Esherichia coli K 12. In Overproduction of Microbiol Products, eds.
    V. Krumphanzl, B. Sikyta, Z. Vanek, pp. 417 423. Academic Press, London.

  3. Peraino, C., W.L. Richards, and F.J. Stevens. 1983. Multistage hepatocarcinogenesis. In
    Mechanisms of Tumor Promotion, Vol.I, Tumor Promotion in Internal Organs, ed. T.J. Slaga,
    pp. 1 53. CRC Press.

  4. Stevens, F.J. and C. Peraino. 1983. Liver as a model system for analyzing mechanisms of tumor
    initiation and promotion. In Organ and Species Specificity in Chemical Carcinogenesis, eds.
    R. Langenbach, S. Nesnow and J.M. Rice, Plenum Press, pp. 231 252.

  5. Stevens, F.J. 1989. Size exclusion high performance liquid chromatography in analysis
    of protein and peptide epitopes. Methods in Enzymology 178: 107 130.

  6. Stevens, F.J. 1991. Considerations of the interpretation of the specificity of monoclonal antibodies
    determined in solid phase immunoassays. In The Immunochemistry of Solid Phase
    Immunoassays, pp 233 242, ed. J.E. Butler, CRC Press, New York.

  7. Spangler, B.D., G.D. Armstrong, and F.J. Stevens. 1992. HPLC analysis of pertussis toxin
    binding to glycoproteins, in Bacterial Protein Toxins (5), pp 300 301,
    Witholt et al., eds., Gustav Fischer Verlag, Stuttgart.

  8. Stevens, F.J. and M. Schiffer. 1995. Structure and properties of human immunoglobulin
    light chain dimers, in Methods in Molecular Biology, Vol 51: Antibody Engineering Protocols,
    ed. S. Paul., pp 51-81. Humana Press Inc, Totowa, NJ.

  9. Schiffer, M. and F.J. Stevens. 1995. Crystallographic and chromatographic methods for study of
    antibody light chains and other proteins, in Methods in Molecular Biology, Vol 51: Antibody
    Engineering Protocols, ed. S. Paul., pp 83-98. Humana Press Inc, Totowa, NJ.

  10. Anderson, L.E., H.C. Huppe, A.D. Li, and F.J. Stevens. 1996. The sedoheptulose bisphosphatase
    of Chlamydomonas reinhardtii contains a potential inter-domain disulfide and is redox-sensitive.
    Proceedings of Xth International Photosynthesis Congress, Montpellier, France. In
    Photosynthesis from Light to Biosphere, Vol. V, pp 71-74. Ed, P. Mathis.

  11. Stevens, F.J., D.T. Weiss, and A. Solomon. 1998. Structural bases of light chain-related pathology. In The Antibodies, Vol 5, pp 175-208. M. Zanetti and J.D. Capra, eds. Harwood Academic Publishers, Australia

  12. Raffen, R. and Stevens, F.J. 1999. Small-zone, high-speed gel filtration chromatography to detect
    protein aggregation associated with light chain pathologies. Meth. Enzymol. 309: 318-332.

  13. Stevens, F.J., M. Schiffer, and Y. Argon. 2002. Thermodynamic aspects of immunoglobulin
    light chain disease. In Conformational Diseases – A Compendium. Based on the First International Workshop on Conformational Diseases, pp 135-150, ed B. Solomon, A. Taraboulos, and E. Katchalski-Katzir. The Center for the Study of Emerging Diseases.

  14. Wilton, R., E.A. Myatt, and F.J. Stevens. 2003. SCIMMS: Simulated chromatography of interactive
    macromolecular systems. In Protein-Protein Interactions: Methods and Protocols, ed. H. Fu, Humana Press, Totowa, NJ.

  15. Kay, B.K., M. Scholle, and F.J. Stevens 2004. EH domains and their ligands. (in press)

  16. Stevens, F.J. 2004. Amyloid proteins. Immunoglobulin (AL, AH). In Amyloid Proteins:
    The Beta Pleated Sheet Conformation and Disease, ed J. Sipe, Wiley.

PUBLICATIONS (peer reviewed):

  1. Stevens, F.J. and T.T. Wu. 1976. Growth on D lyxose of a mutant strain of Escherichia coli
    K 12 using a novel isomerase and enzymes related to D xylose metabolism. J. Gen. Microbiol.
    97: 257 265.

  2. Stevens, F.J., H.S. Pankratz, and R.L. Uffen. 1977. Demonstration of two 3,3' diaminobenzidine
    reactions associated with photosynthetic membranes in anaerobic, light grown Rhodospirillum
    rubrum. J. Histochem. Cytochem. 25: 1264 1268.

  3. Stevens, F.J., F. Westholm, A. Solomon, and M. Schiffer. 1980. Self association of human
    immunoglobulin I light chains: role of the third hypervariable region. Proc. Natl. Acad. Sci
    USA 77: 1144 1148.

  4. Peraino, C., E. Staffeldt, D.A. Haugen, L.S. Lombard, F.J. Stevens, and R.J.M. Fry. 1980. Effects
    of varying the dietary concentration of phenobarbital on its enhancement of
    2 acetylaminofluorene induced hepatic tumorigenesis. Cancer Res. 40: 3268 3273.

  5. Boernke, W.E., F.J. Stevens, and C. Peraino. 1981. Effects of self association of
    ornithine aminotransferase on its physico chemical characteristics. Biochemistry 20: 115 121.

  6. Stevens, F.J., P.W. Stevens, J.G. Hovis, and T.T. Wu. 1981. Some properties of
    D mannose isomerase from Escherichia coli K 12. J. Gen. Microbiol. 124: 219 223.

  7. Stevens, F.J., F.A. Westholm, N. Panagiotopoulos, A. Solomon, and M. Schiffer. 1981.
    Preliminary crystallographic data on the human λ III Bence Jones dimer Cle.
    J. Molec. Biol. 147: 179 183.

  8. Stevens, F.J., F.A. Westholm, N. Panagiotopoulos, M. Schiffer, R.A. Popp, and A. Solomon.
    1981. Characterization and preliminary crystallographic data from the VL related fragment of the
    human I Bence Jones protein Wat. J. Molec. Biol. 147: 185 193.

  9. Stevens, F.J. and M. Schiffer. 1981. Computer simulation of protein self association during
    small zone gel filtration: estimation of equilibrium constants. Biochem. J. 195: 213 219.

  10. Schiffer, M., F.J. Stevens, F.A. Westholm, D. Carlson, and B. Schoenborn. 1982. Small
    angle neutron scattering study of Bence Jones protein Mcg: comparison of structures in solution and in crystal. Biochemistry 21: 2874 2878.

  11. Gierczak, J.S., F.J. Stevens, H.S. Pankratz, and R.L. Uffen. 1982. Cytochemical localization
    and measurement of aerobic 3,3' diaminobenzidine oxidation reactions in photosynthetically grown Rhodospirillum rubrum . J. Histochem. Cytochem. 30: 901 907.

  12. Boernke, W.E., F.J. Stevens, J.E. Edwards, and C. Peraino. 1982. Differential changes in
    ornithine aminotransferase self affinity produced by exposure to basic amino acids and increases
    in the intrinsic electronegativity of the enzyme monomer. Arch. Biochem. Biophys. 216:
    152 157.

  13. Short, M.T., W.J. Eisler, and F.J. Stevens. 1983. Automated failsafe control system for
    independent operation of two radiation shutters on a rotating anode X ray source. J. Appl.
    Crystal. 16: 359 360.

  14. Short, M.T., F.A. Westholm, M. Schiffer, and F.J. Stevens. 1985. Comparison of
    chromatographic characteristics of homologous Bence Jones proteins during size -exclusion
    chromatography by HPLC and by Sephadex. J. Chromatog. 323: 418 423.

  15. Chang, C. H., M.T. Short, F.A. Westholm, F.J. Stevens, B. C. Wang, W. Furey, A. Solomon,
    and M. Schiffer. 1985. A novel arrangement of immunoglobulin variable domains: X ray
    crystallographic analysis of the λ chain dimer, Bence Jones protein Loc. Biochemistry
    24: 4890 4897.

  16. Schiffer, M., C. H. Chang, and F.J. Stevens. 1985. Formation of an infinite  sheet arrangement
    dominates the crystallization behavior of λ-type antibody light chains. J. Mol. Biol.
    186: 475 478.

  17. Peraino, C., B.A. Carnes, and F.J. Stevens. 1986. Evidence for growth heterogeneity among
    different phenotypes in the population of histochemically detectable altered hepatocyte foci
    induced in a single neonatal treatment with carcinogen. Carcinogenesis 7: 191 192.

  18. Stevens, F.J. 1986. Analysis of protein protein interaction by simulation of small zone
    size exclusion chromatography: application to an antibody antigen association. Biochemistry
    25: 981-993.

  19. Stevens, F.J., D.A. LeBuis, W.J. Eisler, and C.F. Ainsworth. 1986. Macromolecular interactions:
    application of microcomputer controlled, high speed, size exclusion chromatography. Liquid
    Chromatography Gas Chromatography 4: 340 348.

  20. LeBuis, D.A., F.J. Stevens, and W.J. Eisler. 1986. An interface to provide microcomputer control
    of a motorized liquid chromatography sample injection valve. Liquid Chromatography Gas
    Chromatography 4: 663 666.

  21. Stevens, F.J., J. Jwo, W. Carperos, H. Köhler, and M. Schiffer. 1986. Relationships between
    liquid and solid phase antibody association characteristics: implications for the use of
    competitive ELISA techniques to map the spatial locations of idiotopes. J. Immunol
    137: 1937 1944.

  22. Stevens, F.J. and M. Schiffer. 1987. Immunoglobulin structural diversities and idiotypic
    expression. International Rev. Immunol. 2: 357 378.

  23. Stevens, F.J. 1987. Modification of an ELISA based procedure for affinity determination:
    correction necessary for use with bivalent antibody. Molec. Immunol. 24: 1055 1060.

  24. Murao, S I., F.J. Stevens, A. Ito, and E. Huberman. 1988. Myeloperoxidase: a myeloid cell
    nuclear antigen with DNA binding properties. Proc. Natl. Acad. Sci. USA 85: 1232 1236.

  25. Stevens, F.J., W. Carperos, W.J. Monafo, and N.S. Greenspan. 1988. Size exclusion HPLC
    analysis of epitopes. J. Immunol. Methods 108: 271 278.

  26. Peraino, C., B.A. Carnes, F.J. Stevens, E.F. Staffeldt, J.J. Russell, A. Prapuolenis, J.A. Blomquist,
    S.D. Vessilinovitch, and R.R. Maronpot. 1988. Comparative developmental and phenotypic
    properties of altered hepatocyte foci and hepatic tumors. Cancer Res. 48: 4171 4178.

  27. Stevens, F.J., C. H. Chang, and M. Schiffer. 1988. Dual conformations of an immunoglobulin
    light chain dimer: heterogeneity of antigen specificity and idiotope profile may result from
    multiple variable domain interaction mechanisms. Proc. Natl. Acad. Sci. USA 85: 6895 6899.

  28. Schiffer, M., C. H. Chang, V.M. Naik, and F.J. Stevens. 1988. Analysis of immunoglobulin
    domain interactions: evidence for dominant role of salt bridges. J. Mol. Biol. 203: 799 802.

  29. Schiffer, M., C. Ainsworth, Z. B. Xu, W. Carperos, K. Olsen, A. Solomon, F.J. Stevens,
    and C. H. Chang. 1989. The structure of a second crystal form of Bence Jones protein Loc: strikingly different domain associations in two crystal forms of a single protein. Biochemistry 28: 4066 4072.

  30. Stevens, F.J. 1989. Analysis of protein protein interaction by simulation of small zone
    size exclusion chromatography: stochastic formulation of kinetic rate contributions to observed
    elution characteristics. Biophysical Journal 55: 1155 1167.

  31. Myatt, E.A., P.T.P. Kaumaya, and F.J. Stevens. 1989. Applications of size exclusion HPLC in
    the analyses of peptide epitopes. BioChromatography 4: 282 289.

  32. Stevens, F.J. 1990. Fractionation of macromolecules in an alternating transverse electric field:
    simulation of the method. J. Biochem. Biophys. Meth. 20: 275 292.

  33. Stevens, F.J., A. Solomon, and M. Schiffer. 1991. Bence Jones proteins: powerful tool for
    fundamental study of protein chemistry and pathophysiology. Biochemistry 30: 6803 6805.

  34. Myatt, E.A., F.J. Stevens, and P.B. Sigler. 1991. Self association properties of two dimeric
    phospholipases A 2. J. Biol. Chem. 266: 16331 16335.

  35. M. Schiffer, C. H. Chang, and F.J. Stevens. 1992. The functions of tryptophan residues in
    membrane proteins. Protein Engineering 5: 213 214.

  36. Stevens, F.J. and E.A. Myatt. 1992. Polymerization of immunoglobulin domains: a model system
    for the development of facilitated macromolecular assembly. Nanotechnology 2: 206 213.

  37. Kolmar, H., C. Frisch, G. Kleemann, K. Goetz, F.J. Stevens, and H. J. Fritz. 1994. Dimerization
    of Bence Jones proteins: linking the rate of transcription from an Escherichia coli promoter to
    the association constant of REIv. Biol. Chem. Hoppe Seyler's Z. 375: 61 70.

  38. Myatt E.A., F.A. Westholm, D. T. Weiss, A. Solomon, M. Schiffer, and F.J. Stevens. 1994.
    Pathogenic potential of monoclonal human immunoglobulin light chains: relationship of in vitro
    aggregation to in vivo organ deposition. Proc. Natl. Acad. Sci. 91: 3034 3038.

  39. Li, D., F.J. Stevens, M. Schiffer, and L.E. Anderson. 1994. Identification of redox sensitive
    cysteines distal to catalytic site in light activated chloroplase enzymes. Biophys. J. 67: 29 35.

  40. Peak, M.J., F.J. Stevens, J.G. Peak, and M.W.W. Adams. 1994. The hyperthermophilic
    glycolytic enzyme enolase in the archaeon, Pyrococcus furiosus: comparison with mesophilic
    enolases. Arch. Biochm. Biophys. 313: 280 286

  41. Huang, D. B., C. H. Chang, C. Ainsworth, A.T. Brünger, M. Eulitz, A. Solomon, F.J. Stevens,
    and M. Schiffer. 1994. Comparison of crystal structures of two homologous proteins: structural
    origin of altered domain interactions in immunoglobulin light chain dimers. Biochemistry
    33: 14848-14857

  42. Myatt, E.A., F.J. Stevens, and C. Benjamin. 1994. Solution phase binding of monoclonal
    antibodies to bee venom phospholipase A2. J. Immunological Methods 177: 35-42.

  43. Wilkins Stevens, P., R. Raffen, D.K. Hanson, Y. L. Deng, M. Berrios Hammond, F.A.
    Westholm, C. Murphy, M. Eulitz, R. Wetzel, A. Solomon, M. Schiffer, and F.J. Stevens.
    1995. Recombinant immunoglobulin variable domains generated from synthetic genes provide a
    system for in vitro characterization of light chain amyloid proteins. Protein Science 4: 421-432.

  44. Anderson, L.E., D. Li, N. Prakash, F.J. Stevens. 1995. Identification of potential
    redox sensitive cysteines in cytosolic forms of fructosebiphosphatase and glyceraldehyde 3
    phosphate dehydrogenase. Planta 196: 118-124.

  45. Pacold, M.E., L.E. Anderson, D. Li, and F.J. Stevens. 1995. Redox sensitivity and light
    modulation of enzyme activity in the rhodophytes Gracilaria tikvahiae and Chondrus crispus.
    J. Phycol. 31: 297-301.

  46. Muslin, E.H., D. Li, F.J. Stevens, M. Donnelly, M. Schiffer, and L. Anderson. 1995 Engineering
    a domain locking disulfide into a bacterial malate dehydrogenase produces a redox sensitive
    enzyme. Biophys. J. 68: 2218-2223.

  47. Pacold, M.E., F.J. Stevens, D. Li, and L.E. Anderson. 1995. The NADP linked
    glyceraldehyde 3 P dehydrogenases of Anabena variabilis and Synechocystis PCC 6803 which
    lack one of the cysteines found in the higher plant enzymesare not reductively activated.
    Photosyn. Res. 43: 125 130.

  48. Paul, S., L. Li, P. Wilkins-Stevens, F.J. Stevens, and A. Solomon. 1995. Natural catalytic
    antibodies: peptide hydrolyzing activities of Bence Jones proeins and a VL domain. J. Biol.
    Chem 270: 15257-15261.

  49. Stevens, F.J., E.A. Myatt, C.-H. Chang,F.A. Westholm,M. Eulitz, D.T. Weiss, C. Murphy, A.
    Solomon, and M. Schiffer. 1995. A molecular model for the formation of amyloid:
    Immunoglobulin light chains. Biochemistry 34: 10697-10702.

  50. Boernke, W.E., C. Sanville Millard, S.N. Kakar, V. Jackiw, M. Schiffer, F.J. Stevens, and
    M.I. Donnelly. 1995. Stringency of substrate specificity of Escherichia coli malate
    dehydrogenase. Arch. Bioch. Biophys 322: 43-52.

  51. Shearer, M.H., F. J. Stevens, F.A. Westholm, H.B. Jenson, T.C. Chanh, K.D. Carey, G.L. White,
    and R.C. Kennedy. 1995. Serological crossreactions among primate immunoglobulins. Devel.
    and Comp. Immunol. 19: 547-557.

  52. Gallo, G. F. Goni, F. Boctor, R. Vidal, A. Kumar, F.J. Stevens, B. Frangione, and J. Ghiso. 1996
    Light chain cardiomyopathy: Structural analysis of the light chain tissue deposits. Am J. Pathol
    148: 1397-1406.

  53. Huang,D.-B., C.A. Ainsworth, F.J. Stevens, and M. Schiffer. 1996. Three quaternary structures
    for a single protein. Proc. Natl. Acad. Sci. 93: 7017-7021.

  54. Anderson, L., H.C. Huppe, L. Dong, F.J. Stevens. 1996. Identification of a potential redox-
    sensitive inter-domain disulfide in the sedoheptulosebisphosphatase of Chlamydomonas
    reinhardtii. Plant J. 10: 553-560.

  55. Levine, D., M. Facello, P. Hallstrom, G. Reeder, B. Walenz, and F.J. Stevens. 1997 STALK:
    An interactive virtual molecular docking system. Comp. Sci. and Engineer. 4:55-65.

  56. Li, A.D, F.J. Stevens, H.C. Huppe, R. Kersanach, and L.E. Anderson. 1997. Chlamydomanas
    reinhardtii NADP-linked glyceraldehyde-3-phosphated dehydrogenase contains the same Cys
    residues identified as potentially domain-locking in the higher plant enzyme and is light
    activated. Photosyn. Res. 51: 167-177.

  57. Anderson, L.E., A. Dong Li, S.C. Nehrlich, M.H. Hill, and F.J. Stevens. 1997. The cytosolic
    fructose bisphosphatase of Brassica napus contains a new potential regulatory disulfide and is
    redox-sensitive. Plant Sci. 128: 23-30.

  58. Jiang X, E. Myatt, P. Lykos, and F.J. Stevens. 1997. Interaction between glycosaminoglycans
    and immunoglobulin light chains. Biochemistry 36: 13187-13194.

  59. Stevens, F.J., Anderson, L.E., A. Dong Li, and S. Salman Lateef. 1997. Identification of
    potential inter-domain disulfides in three higher plant mitochondrial citrate synthases:paradoxical
    differences in redox-sensitivity as compared with the animal enzyme Photosyn. Res. 54:
    185-197

  60. Anderson, L.E., D. Li, E.H. Muslin, F.J. Stevens, and M. Schiffer. 1997. Predicting redox-
    sensitive cysteines in plant enzymes by homology modeling. Comp.Rendu Acad. Sci, Paris
    320: 767-781.
  61. Deret, S., J. Chomilier, D.-B. Huang, J.-L. Preud'homme, F.J. Stevens, and P. Aucouturier.
    1997. Molecular modelling of immunoglobulin light chains implicates hydrophobic residues in
    non-amyloid light chain deposition disease. Protein Engineering 10: 1191-1197.

  62. Anderson, L.E., A.D. Li, and F.J. Stevens. 1998. The enolases of ice plant and arabidopsis
    contain a potential disulfide and are redox-sensitive. Phytochem 47: 707-713.

  63. Muslin, E.H., F.J.Stevens, and L.E. Anderson. 1998. New domain-locking disulfides into a
    bacterial malate dehydrogenase strengthens evidence for original model of reductive activation of
    the chloroplast enzyme. Photosyn. Res. 55: 75-82

  64. Huang, D.-B., C.-H. Chang, C. Ainsworth, G. Johnson, M. Eulitz, A. Solomon, F.J. Stevens, and
    M. Schiffer. 1998. Variable domain structure of the human IV light chain Len: high homology
    to the murine light chain McPC603. Molec. Immunol.34: 1291-1301.

  65. Raffen, R., P. Wilkins Stevens, M. Schiffer, and F.J. Stevens. 1998. Reengineering
    immunoglobulin domain interactions by introduction of charged residues. Protein Engineering
    11: 303-309.
  66. Schiffer, M., D.-B. Huang, P.R. Pokkuluri, R. Raffen, G. Johnson, P. Wilkins Stevens, and
    F.J. Stevens. 1998. A domain flip as a result of a single amino acid substitution.
    Structure 6: 1067-1073.

  67. Hellman, R., M. Vanhove, A. Leujeune, F.J. Stevens, and L.M. Hendershot. 1998. The in vivo
    association of BiP with newly synthesized proteins is dependent on the rate and stabilty of
    folding and not simply on the presence of sequences that can bind to BiP. J. Cell. Biol.
    144: 21-30.

  68. Raffen, R., C. Wunschl, P.R. Pokkulur, P. Dave, P. Wilkins Stevens, M. Schiffer, and
    F.J. Stevens. 1999. Physicochemical consequences of amino acid variations that contribute to
    fibril formation by immunoglobulin light chains. Protein Science 8: 509-517.
  69. Deret, S., L. Denoroy, M. Lamarine, R. Vidal, B. Mougenot, B. Frangione, F.J. Stevens, P.M.
    Ronco and P. Aucouturier. 1999. Myeloma-associated Fanconi's syndrome: Molecular analyses
    of monoclonal immunoglobulin light chains from patients with and without intracellular crystals.
    Protein Engineering 12: 363-369.

  70. Stevens, F.J. and Y. Argon. 1999. Pathogenic light chains and the B cell repertoire
    Immunology Today 20: 451-457.

  71. Davis, D.P., Khurana, R., S. Meredith, F.J. Stevens, and Y. Argon. 1999. Mapping the major
    interaction between binding protein and Ig light chains to sites within the variable domains.
    J. Immunol. 163: 3842-3850.

  72. Stevens, F.J. and Y. Argon. 1999. Protein folding in the ER. Semin. Cellular. Devel. Biol. 10:
    443-454.

  73. Pokkuluri, P.R., M. Klebig, A. Solomon, F.J. Stevens, and M. Schiffer. 1999. Tertiary structure
    of human λ6 light chains. Amyloid: Int. J. Exp. Clin. Invest. 6: 165-171.

  74. Wall, J., M. Schel, C. Murphy, R. Hrncic, M. Klebig, R. Wetzel, F.J. Stevens, and A.
    Solomon. 1999. The thermodynamic stability of two λ6 VL proteins correlates with
    fibrillogenicity. Biochemistry 38: 14101-14108

  75. Vidal, R., F. Goni, F.J. Stevens, P. Aucouturier, A. Kumar, B. Frangione, J. Ghiso, and G. Gallo.
    1999. Somatic mutation of the L12a gene in VκI light chain deposition disease: potential effects
    on abberrant protein conformation and deposition. Am. J. Pathol. 155: 2009-2017.

  76. Stevens, F.J. and R. Kisilevsky. 2000. Immunoglobulin light chains, glycosaminoglycans and
    amyloid. Cell. Molec. Life Sci. 57: 441-449.
  77. Stevens, F.J. 2000. Four structural risk factors identify most fibril-forming kappa light chains.
    Amyloid 7: 200-211.

  78. Pokkuluri, P.R., X. Cai, F.J. Stevens, and M. Schiffer. 2000. Change in dimerization mode by
    removal of a single unsatisfied polar residue. Protein Sci. 9: 1852-1855

  79. Setterdahl, A., M. Hirasawa, L.M. Bucher, C.A. Dholakia, P. Jacquot, H. Yards, F. Miller,
    F.J. Stevens, D.B. Knaff, and L.E.Anderson. 2000. Oxidation-reduction properties of two
    engineered redox-sensitive mutant Escherichia coli malate dehydrogenases. Arch. Bioch.
    Biophys. 382: 15-21

  80. Davis, D.P., R. Raffen, J.L. Dul, S. Vogen, E.K. Williamson, F.J. Stevens, and Y. Argon. 2000.
    Inhibition of amyloid fiber assembly by both BiP and its target peptide. Immunity 13: 433-442.

  81. Stevens, F.J., P.R. Pokkuluri, and M. Schiffer. 2000. Protein conformation and disease:
    Pathological consequences of analogous changes in homologous proteins. Biochemistry
    39: 15291-15296.
  82. Kim, Y.-S., S.P. Cape, E. Chi, R. Raffen, P. Wilkins-Stevens, F.J. Stevens, M.C. Manning, T.W.
    Randolph, A. Solomon, and J.F. Carpenter. 2000. Counteracting effects of renal solutes on
    amyloid formation by immunoglobulin light chains. J. Biol. Chem. 276: 1626-1633.

  83. Louise E. Anderson, L.E., A. Dong Li, E. H. Muslin, M. Schiffer, and F.J. Stevens. 2000.
    Identifying redox-sensitive extra-chloroplastic enzymes by homology modeling.
    Physiol Plantarum 110: 296-303.

  84. Dul, J.L., D.P. Davis, F.J. Stevens, and Y. Argon. 2001. Hsp70 and anti-fibrillogenic
    peptides promote degradation and inhibit intracellular aggregation of amyloidogenic light chains.
    J. Cell. Biol. 152: 705-716.

  85. Lin, Y-M., R. Raffen, Y. Zhou, M.T. Flavin, and F.J. Stevens. 2001. Amyloid fibril formation in
    microwell plates for screening of inhibitors. Amyloid 8: 182-193.

  86. Stevens, F.J. 2001. Caveat receptor: proteomes on display. Comb. Chem. & High Throughput
    Screening 4: 599-602.

  87. Davis, D., S. G. Gallo, S.M. Vogen, J.L. Dul, K.L. Sciarretta, A. Kumar, R. Raffen, F.J. Stevens,
    and Y. Argon. 2001. Both the environment and somatic mutations govern the aggregation
    pathway of pathogenic immunoglobulin light chains. J. Mol. Biol. 313: 1043-1056.

  88. Pokkuluri, P.R., R. Raffen, L. Dieckman, C. Boogaard, F.J. Stevens, and M. Schiffer. 2002.
    Increasing protein stability by polar surface residues: domain-wide consequences of interactions
    within a loop. Biophysical J. 82: 391-398.

  89. Zavaljevski, N., F.J. Stevens, and J. Reifman. 2002. Support vector machines for protein
    classification and identification of key amino acid positions. Bioinformatics 18: 689-696.

  90. Pokkuluri, P.R., M. Gu, X. Cai, R. Raffen, F.J. Stevens, and M. Schiffer. 2002. Factors contributing to decreased protein stability when aspartic acid residues are in β-sheet regions. Protein Sci. 11:1687-1694

  91. Kim, Y.-S., T.W. Randolph, F.J. Stevens, and J.F. Carpenter. 2002. Kinetics and energetics of
    assembly, nucleation, and growth of aggregates and fibrils for an amyloidogenic protein.
    J. Biol. Chem. 277: 27240-27246.

  92. Kim, Y-S., T.W. Randolph, M.C. Manning, F.J. Stevens, and J.F. Carpenter. 2003. Congo red populates partially unfolded states of an amyloidogenic protein to enhance aggregation and amyloid fibril formation. J. Biol. Chem. 278: 10842-10850.

  93. Vilim, R.B., R.M. Cunningham, B. Lu, P. Kheradpour, and F.J. Stevens. 2004. Fold-specific protein classifier for protein classification. Bioinformatics 20: 839-846.

  94. Coriu, D., A. Dispenzieri, F.J. Stevens, C.L. Murphy, S. Wang, D.T. Weiss and A. Solomon.
    2004. Hepatic amyloidosis resulting from deposition of the apolipoprotein A-I variant Leu75Pro.
    Amyloid 10: 215-223

  95. Wu, W., J.T. Watson, F.J. Stevens, R.Yousefzai, and L.E. Anderson. 2004. Mass spectrometric
    evidence for an alternated disulfide bond in chloroplast fructose bisphosphatase. Photosyn. Res.
    79: 189-200.

  96. Gidalevitz, T. C. Biswas, H. Ding, D. Duhovny, H.J. Wolfson, F. Stevens, S. Radford, and Y. Argon. (2004) Identification of the N-terminal peptide binding site of GRP94. J. Biol. Chem. 279: 16543-16552

  97. Stevens, F.J. 2004. Hypothetical structure of SAA: Helical bundle may be
    destabilized by proteolytic processing resulting in fibril formation. Amyloid 11: 71-80.

  98. Stevens, F.J. 2004. Efficient recognition of protein fold in the twilight and midnight zones by conservative application of Psi-BLAST: Validation. J. Molecular Recognition. 18: 139-149.

  99. Stevens, F.J., C. Kuemmel, G. Babnigg, and F. Collart. 2004. Efficient recognition of protein fold in the twilight and midnight zones by conservative application of Psi-BLAST: Application. J. Molecular Recognition 18: 150-157.

  100. Stevens, F.J. 2004. Amyloid formation: An emulation of matrix protein assembly? Amyloid
    11: 232-244.

  101. Wall, J. , V. Gupta, M. Wilkerson, R. Loris, P. Adams, A. Solomon, F.J. Stevens, and C. Dealwis. (2004) Structural basis of light chain amyloidogenicity: Comparison of the thermodynamic properties, fibrillogenic potential, and tertiary structural features of four V(lambda)6 proteins. J. Molec. Recognition 17: 323-331.

  102. Pirun, M., G. Babnigg, and F.J. Stevens. 2005. Template-based recognition of protein fold within
    the midnight and twilight zones of protein sequence similarity. J. Molec. Recogn. 18: 203-212.

  103. Bobrovnik, S.A. and F.J. Stevens. 2004. Evaluation of the intramolecular interaction of
    complementary domains, connected with a flexible chain. (in Russian) Ukr. Biochem. J.
    76: 148-150.

  104. Yu, C., N. Zavaljevski, F.J. Stevens, K. Yackovich, and J. Reifman. 2005. Classifying noisy
    protein sequence data: a case study of immunoglobulin light chains. Bioinformatics (in press).

  105. Ghadge, G.D., L. Wang, K. Sharma, A.L. Monti, V. Bindokas, F.J. Stevens, and R.P. Roos. 2005.
    Electroporation of truncated and mutant SOD2 into the chick embryo spinal cord: A critical role
    for protein misfolding in neuronal death. J. Neurology (in press)

  106. Stevens, F.J. 2005. Modeling multiple p53 binding sites in BRCA1. (in preparation)

  107. Gu, M., R. Wilton, M. Szpunar, and F.J. Stevens. 2005. Fibril restriction by disulfide bonds:
    aggressive fibrillogenesis by RNaseA. (in preparation)
  108. Gu. M., P. Pokkuluri, M. Schiffer, and F.J. Stevens. 2005. Binding of ThioflavinT by non-
    fibrillar antibody variable domains. (in preparation)
  109. Stevens, F.J. and A. Solomon. 2005. Amyloidogenic mutations in ApolipoproteinA-1 may be
    predictable and segregate into three classes of energetic consequence. (in preparation)

  110. Stevens, F.J. and A. Solomon. 2005. The database of light chain variable domain sequences from
    patients with plasma cell diseases: A resource for study of folding disorders of immunoglobulins.
    (in preparation).

  111. F. Collart, S. Moy, L. Dieckman, M. Schiffer, J. Fackenthal, G. Green, A. Venkataranian, O.I.
    Olopade, and F.J. Stevens. 2005. Generation of functional subunits of BRCA1: Demonstration
    of p53 and estrogen receptor binding activities. (in preparation)

U.S. Department of Energy The University of Chicago Office of Science - Department of Energy
Privacy & Security Notice | Contact Us | Site Map | Search